Circulating integrin alpha4/beta7+ lymphocytes targeted by vedolizumab have a pro-inflammatory phenotype

Autor: Lord, James D., Long, S. Alice, Shows, Donna M., Thorpe, Jerill, Schwedhelm, Katherine, Chen, Janice, Kita, Mariko, Buckner, Jane H.
Zdroj: In Clinical Immunology August 2018 193:24-32
Databáze: ScienceDirect